Emily Serazin is a Managing Director and Partner at the Boston Consulting Group (BCG). Emily is a core member of BCG’s Health Care and Social Impact practices. Within health care, Emily’s focus is on vaccines and global health across the value chain. She also has expertise in digital health and in the formation and optimization of public-private partnerships. Examples of Emily's experience in the commercial health care sector include developing growth and product launch strategies for players in the global vaccines market, leading due diligences, and supporting post-merger integrations. In the realm of global public health, Emily has worked across leading global health institutions such as Gavi, UNICEF, WHO, and the Bill & Melinda Gates foundation to define investment strategies, coordinate multi-stakeholder efforts, prioritize portfolios, and identify key levers to drive uptake in low- and middle-income countries. Since the start of the Covid-19 pandemic, Emily has worked extensively with public, private and social sector actors to accelerate the development and deployment of Covid-19 vaccines and therapeutics.